Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13417 | 774 | 25.1 | 32% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AMOSULALOL | Author keyword | 6 | 80% | 1% | 4 |
| 2 | TERTATOLOL | Author keyword | 6 | 39% | 2% | 12 |
| 3 | DILEVALOL | Author keyword | 3 | 35% | 1% | 7 |
| 4 | CARBAMOYL GLUCURONIDE | Author keyword | 1 | 50% | 0% | 1 |
| 5 | MILD ESSENTIAL HYPERTENSION | Author keyword | 1 | 50% | 0% | 1 |
| 6 | NONDRUG THERAPY | Author keyword | 1 | 50% | 0% | 1 |
| 7 | BLOOD P SURE CLIN | Address | 0 | 33% | 0% | 1 |
| 8 | RAT LEFT ATRIA | Author keyword | 0 | 33% | 0% | 1 |
| 9 | MEPINDOLOL | Author keyword | 0 | 25% | 0% | 1 |
| 10 | CONCENTRATION EFFECT ANALYSIS | Author keyword | 0 | 20% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AMOSULALOL | 6 | 80% | 1% | 4 | Search AMOSULALOL | Search AMOSULALOL |
| 2 | TERTATOLOL | 6 | 39% | 2% | 12 | Search TERTATOLOL | Search TERTATOLOL |
| 3 | DILEVALOL | 3 | 35% | 1% | 7 | Search DILEVALOL | Search DILEVALOL |
| 4 | CARBAMOYL GLUCURONIDE | 1 | 50% | 0% | 1 | Search CARBAMOYL+GLUCURONIDE | Search CARBAMOYL+GLUCURONIDE |
| 5 | MILD ESSENTIAL HYPERTENSION | 1 | 50% | 0% | 1 | Search MILD+ESSENTIAL+HYPERTENSION | Search MILD+ESSENTIAL+HYPERTENSION |
| 6 | NONDRUG THERAPY | 1 | 50% | 0% | 1 | Search NONDRUG+THERAPY | Search NONDRUG+THERAPY |
| 7 | RAT LEFT ATRIA | 0 | 33% | 0% | 1 | Search RAT+LEFT+ATRIA | Search RAT+LEFT+ATRIA |
| 8 | MEPINDOLOL | 0 | 25% | 0% | 1 | Search MEPINDOLOL | Search MEPINDOLOL |
| 9 | CONCENTRATION EFFECT ANALYSIS | 0 | 20% | 0% | 1 | Search CONCENTRATION+EFFECT+ANALYSIS | Search CONCENTRATION+EFFECT+ANALYSIS |
| 10 | HUMAN GLOMERULAR MESANGIAL CELLS | 0 | 20% | 0% | 1 | Search HUMAN+GLOMERULAR+MESANGIAL+CELLS | Search HUMAN+GLOMERULAR+MESANGIAL+CELLS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | COMBINED ALPHA ADRENOCEPTOR | 9 | 83% | 1% | 5 |
| 2 | YM 09538 | 6 | 100% | 1% | 4 |
| 3 | R R ISOMER | 5 | 63% | 1% | 5 |
| 4 | SCH 19927 | 3 | 60% | 0% | 3 |
| 5 | TERTATOLOL | 2 | 43% | 0% | 3 |
| 6 | DILEVALOL | 1 | 50% | 0% | 2 |
| 7 | LABETALOL METABOLITES | 1 | 100% | 0% | 2 |
| 8 | AROTINOLOL | 1 | 40% | 0% | 2 |
| 9 | BODY FLUID COMPOSITION | 1 | 33% | 0% | 2 |
| 10 | ALPHA BETA BLOCKADE | 1 | 50% | 0% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| LABETALOL - A REAPPRAISAL OF ITS PHARMACOLOGY, PHARMACOKINETICS AND THERAPEUTIC USE IN HYPERTENSION AND ISCHEMIC HEART-DISEASE | 1989 | 31 | 162 | 60% |
| LABETALOL - A REVIEW OF ITS PHARMACOLOGY, PHARMACOKINETICS, CLINICAL USES AND ADVERSE-EFFECTS | 1983 | 61 | 106 | 75% |
| DILEVALOL - A SELECTIVE BETA-2-ADRENERGIC AGONIST VASODILATOR WITH BETA-ADRENERGIC BLOCKING ACTIVITY | 1989 | 7 | 18 | 78% |
| CURRENT STATUS OF LABETALOL, THE 1ST ALPHA-BLOCKING AND BETA-BLOCKING AGENT | 1985 | 18 | 57 | 75% |
| CLINICAL PHARMACOKINETICS OF LABETALOL | 1984 | 35 | 13 | 69% |
| CLINICAL PHARMACOKINETICS AND KINETIC-DYNAMIC RELATIONSHIPS OF DILEVALOL AND LABETALOL | 1991 | 6 | 44 | 64% |
| EFFECTS OF AGE ON THE ELIMINATION OF LABETALOL | 1989 | 3 | 6 | 83% |
| BETA-BLOCKERS AND RENAL-FUNCTION | 1982 | 81 | 7 | 86% |
| RENAL EFFECTS OF ANTIHYPERTENSIVE DRUGS | 1989 | 31 | 116 | 11% |
| Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension | 2014 | 1 | 35 | 11% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BLOOD P SURE CLIN | 0 | 33% | 0.1% | 1 |
| 2 | SERV NEPHROL CONSULTAT HYPERTENS | 0 | 11% | 0.1% | 1 |
| 3 | MED 80 E CONCORD ST | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000227368 | AROTINOLOL//SHICHIMOTSU KOKA TO//SHICHIMOTSUKOKATO |
| 2 | 0.0000221703 | CELIPROLOL//BEVANTOLOL//PERINDOPRIL THERAPEUTIC USE |
| 3 | 0.0000155899 | RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL |
| 4 | 0.0000153658 | REDUCTIVE RING CLOSURE//THERMAL CYCLISATION//PHENOXYBENZAMINE HYDROCHLORIDE |
| 5 | 0.0000121101 | APEXCARDIOGRAPHY//HANDGRIP APEXCARDIOGRAPHIC TEST//DOPPLER ECHO |
| 6 | 0.0000116437 | BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE |
| 7 | 0.0000096100 | DOXAZOSIN//AJ 2615//MONATEPIL MALEATE |
| 8 | 0.0000085132 | ANTIHYPERTENSIVE PHARMACOTHERAPY//BETA1 BLOCKADE//CARDIOVASC P REHABIL UNIT |
| 9 | 0.0000081100 | CLEVIDIPINE//HYPERTENSIVE EMERGENCY//HYPERTENSIVE CRISIS |
| 10 | 0.0000069692 | HAIR DISTRIBUTION//PHYS ACT SPORT RECREAT PHASREC//HART |